Ind-Swift Laboratories Signs ₹40 Crore Warehouse Deal with Him Infratech in Punjab

1 min read     Updated on 28 Jul 2026, 10:13 PM
scanx
Reviewed by
Ashish TScanX News Team
AI Summary

Ind-Swift Laboratories has signed a ₹40 crore MOU with Him Infratech Private Limited to construct a centralized warehouse on ~4.5 acres of leasehold land in Village Jawaharpur, Derabassi, Punjab, adjacent to its existing manufacturing unit. The facility will offer 11,000-pallet storage capacity for raw materials, packing materials, and finished goods, with a construction timeline of 300 days. The transaction is not classified as a related-party deal, as Him Infratech holds no shareholding in the company.

powered bylight_fuzz_icon
46797715

*this image is generated using AI for illustrative purposes only.

Ind-Swift Laboratories has executed a memorandum of understanding with Him Infratech Private Limited for the construction of a centralized warehouse facility, marking a significant step in its infrastructure expansion plans. The agreement, signed on July 28, 2026, carries an estimated contract cost of ₹40 crore and is designed to enhance the company's storage capabilities and logistical efficiency. The new facility will be located on leasehold land spanning approximately 4.5 acres in Village Jawaharpur, Derabassi, Punjab, adjoining the company's existing manufacturing unit in the Global Business Unit.

The warehouse is projected to have a storage capacity of 11,000 pallets, dedicated to holding raw materials, packing materials, and finished goods. Ind-Swift Laboratories disclosed the transaction under Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The filing also referenced SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026. The company confirmed that Him Infratech holds no shareholding in Ind-Swift Laboratories, and the transaction does not classify as a related-party transaction under the Listing Obligations and Disclosure Requirements.

Project Details

The construction timeline for the warehouse facility is set at 300 days, excluding any exigencies. The strategic location adjacent to the existing manufacturing facility in Derabassi allows for seamless integration with current operations. By centralizing storage for raw and finished goods, the company aims to reduce logistical bottlenecks and improve supply chain responsiveness. The absence of any shareholding or promoter-group relationship between the two entities ensures the transaction is conducted at arm's length.

Parameter Details
Contractor Him Infratech Private Limited
Contract Value ₹40 crore
Location Village Jawaharpur, Derabassi, Punjab
Land Area ~4.5 acres (leasehold)
Storage Capacity 11,000 pallets
Construction Timeline 300 days

Strategic Implications

This infrastructure investment underscores Ind-Swift Laboratories' focus on scaling its operational backbone to support future growth. The addition of a high-capacity centralized warehouse addresses potential constraints in storage and distribution, which are critical for maintaining product availability and reducing lead times. With the facility situated near its primary manufacturing hub in Punjab, the company can optimize inventory management and streamline the movement of goods from production to market. The execution of this MOU signals a commitment to long-term operational resilience and efficiency improvements within its supply chain framework.

Historical Stock Returns for Ind Swift Laboratories

1 Day5 Days1 Month6 Months1 Year5 Years
-1.50%+0.99%+15.12%+120.81%+125.72%+120.44%

How will the ₹40 crore capital expenditure impact Ind-Swift Laboratories' near-term cash flow and debt-to-equity ratio?

What specific supply chain bottlenecks is the 11,000-pallet capacity designed to resolve, and what is the expected reduction in lead times?

Given the 300-day construction timeline, when does management expect the new facility to become fully operational and contribute to revenue efficiency?

like19
dislike

Ind-Swift Labs sets EGM for ₹137.2 crore warrant issue

1 min read     Updated on 16 Jul 2026, 09:39 AM
scanx
Reviewed by
Shriram SScanX News Team
AI Summary

Ind-Swift Laboratories Limited has scheduled an Extraordinary General Meeting on August 05, 2026, to seek approval for issuing 70,00,000 warrants to Essix Biosciences Limited at ₹196 each, totaling ₹137.2 crore. The funds will support business expansion and working capital. The meeting, held via VC/OAVM, also covers director re-appointment and AoA alteration. Remote e-voting is open from August 02 to August 04, 2026.

powered bylight_fuzz_icon
44989234

*this image is generated using AI for illustrative purposes only.

Ind-Swift Laboratories Limited has scheduled an Extraordinary General Meeting (EGM) on August 05, 2026, to seek shareholder approval for the preferential allotment of up to 70,00,000 fully convertible warrants to Essix Biosciences Limited, a promoter group entity. The warrants are priced at ₹196 each, aggregating to ₹137.2 crore, and will convert into equity shares within 18 months of allotment. The meeting will also consider the re-appointment of Sh. Rajinder Kumar Gupta as an Independent Director and the alteration of the Articles of Association.

The board meeting held on July 10, 2026, approved the issuance of warrants to raise funds for business expansion, working capital requirements, and general corporate purposes. The preferential issue is subject to the approval of shareholders by way of a special resolution. The company has engaged CDSL as the e-voting agency, with remote e-voting commencing on August 02, 2026, at 9:00 A.M. IST and concluding on August 04, 2026, at 5:00 P.M. IST. The notice of the EGM was dispatched electronically on July 14, 2026, and newspaper advertisements confirming the dispatch were published in Financial Express and Jansatta on July 15, 2026.

Key Issue Details

Detail Information
Allottee Essix Biosciences Limited
Category Promoter & Promoter Group
Number of Warrants Up to 70,00,000
Issue Price ₹196 per Warrant
Total Amount ₹137.2 crore
Conversion Period Within 18 months from allotment

E-Voting Schedule

Shareholders can cast their votes remotely or during the EGM via Video Conferencing (VC) and Other Audio-Visual Means (OAVM). The voting rights are determined based on shareholding as of July 29, 2026, the cut-off date. Members attending via VC/OAVM will be counted for the purpose of Quorum under Section 103 of the Companies Act, 2013. The notice is available on the company's website at www.indswiftgroup.com and the websites of BSE Limited and National Stock Exchange of India Limited. Shareholders holding shares in physical form must send a request to the RTA, Alankit Assignments Limited, in the prescribed Form ISR-1 to register their email address.

Historical Stock Returns for Ind Swift Laboratories

1 Day5 Days1 Month6 Months1 Year5 Years
-1.50%+0.99%+15.12%+120.81%+125.72%+120.44%

How will the infusion of ₹137.2 crore specifically impact Ind-Swift's expansion pipeline over the next two years?

What strategic advantages does Essix Biosciences gain by increasing its stake through these convertible warrants?

How might the conversion of warrants into equity shares affect the company's earnings per share upon dilution?

like17
dislike

More News on Ind Swift Laboratories

1 Year Returns:+125.72%